Ann: Incannex to Acquire APIRx Pharmaceuticals, page-346

Yes Malkazoid as you say that big pump and dump in the early listing didn't do us any favours, if you look at our high and low on the Nasdaq.
96 USD High and 9.36 USD Low, you have to smile, but yes that was one hell of a crazy start.
Anyway it looks like it's finally finding it's place, and if you compare it with ATAI, MINDMED, and COMPASS our Market caps seem to be about right now, because they have more cash on hand than we do.

We have to remember though that the biotech space in psychadelics has been absolutely smashed in the past 6 months these three companies alone, down a whopping 70 to 80% i mean those falls are comparable to the 2008 financial crisis.
The good news is there already 20% up from there lows, so hopefully we can follow in that uptrend.

CognacHennessay . Let's hope it can play out like LKE as you say, it took a while for the market to digest, but eventually it caught on, and look at it now, it's absolutely flying.
So i guess we have to be a little patient here, but if you look at our range of products with their accompanied IP and patents and ongoing trials, , and then add APIRx big collection too . Its huge in comparison to the other three companies we tend to compare ourselves with. Also not forgetting, ours is Psychadelics and cabbinoid, and not just primarily psychadelics. Who knows when This new PR firm that Joel has hired in New York, get out on the road and start spreading the word , t's possible we could even be leading the pack before This year is out.